The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies

Keyphrases

• During Pregnancy 100%
• Neonatal Outcome 100%
• Antidepressants 100%
• Antidepressant Use 100%
• Retrospective Database 100%
• Preterm Delivery 75%
• Congenital Malformations 75%
• Adverse Events 50%
• Claims Database 50%
• Retrospective Cohort 50%
• Respiratory Distress 50%
• Medical Database 50%
• Infant Outcomes 50%
• Seizure 25%
• Fetus 25%
• Pregnant Women 25%
• Prenatal Exposure 25%
• Fetal Exposure 25%
• Convulsion 25%
• Inconsistency 25%
• Low Birth Weight 25%
• Infant Death 25%
• Small-for-gestational Age 25%
• PubMed 25%
• Retrospective Cohort Study 25%
• Low Apgar Score 25%
• Infant Mortality 25%
• Fetal Death 25%
• Persistent Pulmonary Hypertension 25%
• Fetal Mortality 25%
• Retrospective Cohort Design 25%
• Persistent Pulmonary Hypertension of the Newborn 25%
• Majority Consensus 25%
• Cohort Model 25%
• Scientific Endeavor 25%

Medicine and Dentistry

• Antidepressant Medication 100%
• Antidepressant 100%
• Cohort Studies 100%
• Premature Labor 60%
• Congenital Malformation 60%
• Preterm Delivery 60%
• Adverse Event 40%
• Respiratory Distress 40%
• Persistent Fetal Circulation 40%
• Neonatal Infant 20%
• Prenatal Exposure 20%
• Low Birth Weight 20%
• Child Death 20%
• Small for Gestational Age 20%
• Epileptic Seizure 20%
• Retrospective Cohort Study 20%
• Apgar Score 20%
• Fetus Death 20%
• Fetus Mortality 20%
• Infant Mortality 20%
• Pregnant Woman 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidepressant 100%
• Cohort Study 100%
• Premature Labor 42%
• Congenital Malformation 42%
• Adverse Event 28%
• Respiratory Distress 28%
• Persistent Pulmonary Hypertension 28%
• Prenatal Exposure 14%
• Child Death 14%
• Low Birth Weight 14%
• Small for Date Infant 14%
• Fetus Death 14%
• Fetus Mortality 14%
• Infant Mortality 14%